Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
FDA Approves First Generic Version of Lundbeck’s Sabril
RAPS.org
Wed, 01/16/19 - 11:54 pm
FDA
Teva Pharmaceutical
Lundbeck
seizures
generics
Sabril
Vigabatrin
How a 'regulatory dead zone' may be holding up copycat insulin
Biopharma Dive
Mon, 01/14/19 - 11:53 pm
diabetes
insulin
generics
FDA
FDA Gives Amneal's Generic Alzheimer’s & Parkinson’s Patch a Thumbs-Up
BioSpace
Mon, 01/14/19 - 11:32 am
FDA
Amneal
generics
Novartis
Exelon Patch
Alzheimer's disease
Parkinson's Disease
Trump falsely claims ‘drug prices declined in 2018’
Stat
Sun, 01/13/19 - 11:35 am
drug prices
Donald Trump
generics
Klobuchar, Grassley bill would ban 'pay-for-delay' deals
BioCentury
Thu, 01/10/19 - 08:42 pm
legislation
pay-for-delay
generics
The Big Three Generic Drug Mega-Buyers Drove Double-Digit Deflation in 2018. Stability ahead?
Drug Channels
Tue, 01/8/19 - 09:26 am
FDA
generics
Red Oak Sourcing
Walgreens Boots Alliance
Teva and Neos settle over Cotempla patent dispute
Pharmaforum
Thu, 12/27/18 - 10:17 pm
Teva Pharmaceutical
Neos Therapeutics
generics
patents
ADHD
Cotempla XR-ODT
FDA Withdraws Proposed Rule on Generic Label Changes
RAPS.org
Thu, 12/13/18 - 12:26 pm
FDA
labeling
generics
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Fierce Pharma
Thu, 12/13/18 - 12:24 pm
Sanofi
Lantus
Eli Lilly
Boehringer Ingelheim
Mylan Labs
generics
diabetes
insulin
basal insulin
Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178
Stat
Wed, 12/12/18 - 09:56 am
Kaleo
opioids
opioid addiction
generics
Naloxone
Evzio
opioid overdose
Investigation of generic ‘cartel’ expands to 300 drugs
Washington Post, DC
Mon, 12/10/18 - 07:20 pm
generics
price fixing
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Fierce Pharma
Thu, 12/6/18 - 01:37 pm
Novartis
Sandoz
generics
Symjepi
EpiPens
Teva Pharmaceutical
Mylan
Mallinckrodt splitting into 2 with generic spin-off plan
BioPharma Dive
Thu, 12/6/18 - 01:02 pm
Mallinckrodt
generics
spinoffs
Generic Drug Prices ‘Strongly Predictive’ of Shortages, Study Finds
RAPS.org
Tue, 12/4/18 - 07:20 pm
generics
drug shortages
drug pricing
Teva launches EpiPen generic at same price as Mylan's version
Biopharma Dive
Wed, 11/28/18 - 11:52 am
Teva Pharmaceutical
Mylan
EpiPens
generics
Johnson & Johnson shares swoon as pharma giant loses yet another fight to protect Zytiga sales
Fierce Pharma
Tue, 11/27/18 - 12:12 pm
JNJ
generics
Zytiga
Supreme Court
patents
J&J shares fall after court refuses to block Zytiga generics
Pharmaforum
Fri, 11/23/18 - 01:14 pm
JNJ
generics
Zytiga
prostate cancer
White House Report Shows Increase in Generics Competition Saved Americans $26 Billion
BioSpace
Fri, 11/23/18 - 01:07 pm
generics
Healthcare Spending on Branded Prescription Drugs Continues to Rise Despite Availability of More Generics
Xtalks
Sun, 11/18/18 - 12:49 pm
generics
branded pharma
drug spending
Novartis 'completely committed' to Sandoz, has no split-off plan
Yahoo/Reuters
Thu, 11/15/18 - 11:20 am
Novartis
Sandoz
generics
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »